Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)

NCT03515044 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Overt Hepatic Encephalopathy

Interventions

DRUG: 40 mg Rifaximin SSD once daily
DRUG: 40 mg Rifaximin SSD twice daily
DRUG: 80 mg Rifaximin SSD once daily
DRUG: 80 mg Rifaximin SSD twice daily
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.